MIT logo
June 11-13, 2019 • MIT, Cambridge, MA
ucl
 
Images
 

The UCL MBI Industrial Training Programme in collaboration with  Massachusetts Institute of Technology is announcing its 2019 Vaccines Bioprocess Development & Commercialization Workshop.
 
This three-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, development, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process.

  image
     
Workshop Highlights
 

June 11
Speakers
Tarit Mukhopadhyay, Merck & Co
Barry Buckland,
UCL
John Aunins,
Seres
Adrian Hill, Oxford

Dan Barouch, Harvard

June 12
Speakers
Steve Kolodziej, Pfizer
Derek O'Hagan,
GSK
Martin Wisher,
BioReliance
Indresh Srivastava,
Sanofi
Stacy Springs,
MIT
Stefanie Frank, UCL

Case Study - Flu Vaccine
Matthew Downham, Astra Zeneca

June 13
Keynote Speaker
Mark Feinberg, IAVI

Speakers
J. Christopher Love, MIT
David Robinson
, B&MGF
José Castillo, Univercells
Rahul Singhvi, Takeda

 

June 13 Panel Discussion
Responding in Time: Dealing with Predictable and Unpredictable
Moderator: Stacy Springs, MIT
Panel Members Include: Drusilla Burns, FDA | Keith Chidwick, PAREXEL Consulting | David Robinson, B&MGF | Jayanthi Wolf, Merck

This workshop is suitable for:

  • Scientists and engineers new to the vaccines sector (recent graduates / research scientists).
  • Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms, exploring the interplay between process choices and regulation.
  • Project Managers, funders and policy-makers wanting to gain an understanding in vaccines.

MBI Background - 25 years ago UCL Biochemical Engineering created the award winning MBI training programme to provide a series of innovative UCL-accredited short courses in bioprocessing. These courses are designed for industry in collaboration with experts to support continued professional and technical development. Courses are designed for flexible professional and technical development with options for achieving up to Masters level qualifications.

MIT CBI MBI